At last a male contraceptive jab!

NewsGuard 100/100 Score

At last a male contraceptive jab has been developed and is all set to be trialled - and Sydney men will be the first guinea pigs!

The new male contraceptive which has been developed by researchers at Concord Hospital's Anzac Research Institute is a world first and will offer men control over their own fertility.

Sydney men will be among the first in the world to try a new two-monthly male contraceptive injection which works exactly like the female contraceptive pill by shutting down the reproductive function.

The contraceptive injection which tricks the brain into thinking it has already produced sperm, without affecting men's sexuality was found in earlier studies to work in 95% of men - and the men became fully fertile again three months after they stop having the injections.

The worldwide trial involves 10 centres including Sydney and Melbourne's Prince Henry Institute and according to lead researcher Professor Rob McLachlan the treatment keeps men's testosterone levels normal while the progestin fools the brain into not producing hormones needed to stimulate sperm production.

Dr. McLachlan says sexual function should not change because the level of testosterone in the blood remains the same.

Four hundred couples are being sought to take part in the 18-month trial which will test the effectiveness of the injection as the only form of contraception.

Any couples interested in becoming involved are asked to ring 0767 7222 or email [email protected]. for more information.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UQ research finds molecular doorways to help deliver drugs into the brain